nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—atopic dermatitis—asthma	0.596	1	CtDrD
Pimecrolimus—CYP3A4—Fluticasone furoate—asthma	0.0167	0.0796	CbGbCtD
Pimecrolimus—CYP3A4—Budesonide—asthma	0.0149	0.0709	CbGbCtD
Pimecrolimus—CYP3A4—Ciclesonide—asthma	0.0136	0.0649	CbGbCtD
Pimecrolimus—CYP3A4—Indacaterol—asthma	0.0136	0.0649	CbGbCtD
Pimecrolimus—CYP3A4—Salbutamol—asthma	0.0127	0.0603	CbGbCtD
Pimecrolimus—CYP3A4—Salmeterol—asthma	0.0127	0.0603	CbGbCtD
Pimecrolimus—CYP3A4—Flunisolide—asthma	0.0127	0.0603	CbGbCtD
Pimecrolimus—CYP3A4—Zileuton—asthma	0.0113	0.0538	CbGbCtD
Pimecrolimus—CYP3A4—Ipratropium bromide—asthma	0.0113	0.0538	CbGbCtD
Pimecrolimus—CYP3A4—Fluticasone Propionate—asthma	0.0108	0.0513	CbGbCtD
Pimecrolimus—CYP3A4—Zafirlukast—asthma	0.00994	0.0473	CbGbCtD
Pimecrolimus—CYP3A4—Tiotropium—asthma	0.00855	0.0407	CbGbCtD
Pimecrolimus—CYP3A4—Aminophylline—asthma	0.00816	0.0389	CbGbCtD
Pimecrolimus—CYP3A4—Theophylline—asthma	0.00767	0.0365	CbGbCtD
Pimecrolimus—CYP3A4—Loratadine—asthma	0.00727	0.0346	CbGbCtD
Pimecrolimus—CYP3A4—Montelukast—asthma	0.00727	0.0346	CbGbCtD
Pimecrolimus—CYP3A4—Methylprednisolone—asthma	0.00665	0.0317	CbGbCtD
Pimecrolimus—CYP3A4—Triamcinolone—asthma	0.00504	0.024	CbGbCtD
Pimecrolimus—CYP3A4—Betamethasone—asthma	0.00433	0.0206	CbGbCtD
Pimecrolimus—CYP3A4—Prednisolone—asthma	0.00427	0.0203	CbGbCtD
Pimecrolimus—CYP3A4—Hydrocortisone—asthma	0.00405	0.0193	CbGbCtD
Pimecrolimus—CYP3A4—Prednisone—asthma	0.00403	0.0192	CbGbCtD
Pimecrolimus—CYP3A4—Dexamethasone—asthma	0.00252	0.012	CbGbCtD
Pimecrolimus—MTOR—respiratory system—asthma	0.00143	0.0927	CbGeAlD
Pimecrolimus—FKBP1A—respiratory system—asthma	0.00129	0.0834	CbGeAlD
Pimecrolimus—MTOR—epithelium—asthma	0.0012	0.0775	CbGeAlD
Pimecrolimus—MTOR—smooth muscle tissue—asthma	0.00115	0.0746	CbGeAlD
Pimecrolimus—MTOR—cardiovascular system—asthma	0.0011	0.071	CbGeAlD
Pimecrolimus—FKBP1A—adrenal cortex—asthma	0.00108	0.07	CbGeAlD
Pimecrolimus—FKBP1A—epithelium—asthma	0.00108	0.0697	CbGeAlD
Pimecrolimus—FKBP1A—bronchus—asthma	0.00106	0.0686	CbGeAlD
Pimecrolimus—FKBP1A—smooth muscle tissue—asthma	0.00104	0.0671	CbGeAlD
Pimecrolimus—FKBP1A—cardiovascular system—asthma	0.000987	0.0638	CbGeAlD
Pimecrolimus—FKBP1A—trachea—asthma	0.000952	0.0616	CbGeAlD
Pimecrolimus—MTOR—adrenal gland—asthma	0.000868	0.0561	CbGeAlD
Pimecrolimus—FKBP1A—adrenal gland—asthma	0.000781	0.0505	CbGeAlD
Pimecrolimus—MTOR—lung—asthma	0.000761	0.0492	CbGeAlD
Pimecrolimus—FKBP1A—lung—asthma	0.000684	0.0443	CbGeAlD
Pimecrolimus—Urticaria—Formoterol—asthma	4.06e-05	0.000322	CcSEcCtD
Pimecrolimus—Urticaria—Arformoterol—asthma	4.06e-05	0.000322	CcSEcCtD
Pimecrolimus—Abdominal pain—Arformoterol—asthma	4.04e-05	0.000321	CcSEcCtD
Pimecrolimus—Abdominal pain—Formoterol—asthma	4.04e-05	0.000321	CcSEcCtD
Pimecrolimus—Body temperature increased—Formoterol—asthma	4.04e-05	0.000321	CcSEcCtD
Pimecrolimus—Body temperature increased—Arformoterol—asthma	4.04e-05	0.000321	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Budesonide—asthma	4.03e-05	0.00032	CcSEcCtD
Pimecrolimus—Vomiting—Loratadine—asthma	4.03e-05	0.00032	CcSEcCtD
Pimecrolimus—Vomiting—Tiotropium—asthma	4.02e-05	0.00032	CcSEcCtD
Pimecrolimus—Diarrhoea—Flunisolide—asthma	4.01e-05	0.000319	CcSEcCtD
Pimecrolimus—Rash—Loratadine—asthma	4e-05	0.000318	CcSEcCtD
Pimecrolimus—Pain—Budesonide—asthma	3.99e-05	0.000317	CcSEcCtD
Pimecrolimus—Constipation—Budesonide—asthma	3.99e-05	0.000317	CcSEcCtD
Pimecrolimus—Dermatitis—Loratadine—asthma	3.99e-05	0.000317	CcSEcCtD
Pimecrolimus—Rash—Tiotropium—asthma	3.99e-05	0.000317	CcSEcCtD
Pimecrolimus—Dermatitis—Tiotropium—asthma	3.99e-05	0.000317	CcSEcCtD
Pimecrolimus—Nausea—Aminophylline—asthma	3.99e-05	0.000317	CcSEcCtD
Pimecrolimus—Infestation NOS—Methylprednisolone—asthma	3.98e-05	0.000316	CcSEcCtD
Pimecrolimus—Infestation—Methylprednisolone—asthma	3.98e-05	0.000316	CcSEcCtD
Pimecrolimus—Urticaria—Montelukast—asthma	3.97e-05	0.000316	CcSEcCtD
Pimecrolimus—Headache—Loratadine—asthma	3.97e-05	0.000316	CcSEcCtD
Pimecrolimus—Headache—Tiotropium—asthma	3.96e-05	0.000315	CcSEcCtD
Pimecrolimus—Abdominal pain—Montelukast—asthma	3.95e-05	0.000314	CcSEcCtD
Pimecrolimus—Body temperature increased—Montelukast—asthma	3.95e-05	0.000314	CcSEcCtD
Pimecrolimus—Face oedema—Prednisone—asthma	3.95e-05	0.000314	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Salbutamol—asthma	3.94e-05	0.000313	CcSEcCtD
Pimecrolimus—Conjunctivitis—Triamcinolone—asthma	3.88e-05	0.000308	CcSEcCtD
Pimecrolimus—Pruritus—Mometasone—asthma	3.85e-05	0.000306	CcSEcCtD
Pimecrolimus—Urticaria—Salbutamol—asthma	3.83e-05	0.000304	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Budesonide—asthma	3.82e-05	0.000304	CcSEcCtD
Pimecrolimus—Abdominal pain—Salbutamol—asthma	3.81e-05	0.000303	CcSEcCtD
Pimecrolimus—Body temperature increased—Salbutamol—asthma	3.81e-05	0.000303	CcSEcCtD
Pimecrolimus—Nausea—Loratadine—asthma	3.77e-05	0.000299	CcSEcCtD
Pimecrolimus—Hypersensitivity—Arformoterol—asthma	3.76e-05	0.000299	CcSEcCtD
Pimecrolimus—Hypersensitivity—Formoterol—asthma	3.76e-05	0.000299	CcSEcCtD
Pimecrolimus—Epistaxis—Triamcinolone—asthma	3.76e-05	0.000299	CcSEcCtD
Pimecrolimus—Nausea—Tiotropium—asthma	3.76e-05	0.000299	CcSEcCtD
Pimecrolimus—Vomiting—Flunisolide—asthma	3.73e-05	0.000296	CcSEcCtD
Pimecrolimus—Diarrhoea—Mometasone—asthma	3.72e-05	0.000296	CcSEcCtD
Pimecrolimus—Urticaria—Budesonide—asthma	3.71e-05	0.000295	CcSEcCtD
Pimecrolimus—Rash—Flunisolide—asthma	3.7e-05	0.000294	CcSEcCtD
Pimecrolimus—Dermatitis—Flunisolide—asthma	3.69e-05	0.000294	CcSEcCtD
Pimecrolimus—Abdominal pain—Budesonide—asthma	3.69e-05	0.000293	CcSEcCtD
Pimecrolimus—Body temperature increased—Budesonide—asthma	3.69e-05	0.000293	CcSEcCtD
Pimecrolimus—Hypersensitivity—Montelukast—asthma	3.69e-05	0.000293	CcSEcCtD
Pimecrolimus—Headache—Flunisolide—asthma	3.67e-05	0.000292	CcSEcCtD
Pimecrolimus—Pruritus—Formoterol—asthma	3.61e-05	0.000287	CcSEcCtD
Pimecrolimus—Pruritus—Arformoterol—asthma	3.61e-05	0.000287	CcSEcCtD
Pimecrolimus—Rhinitis—Triamcinolone—asthma	3.59e-05	0.000285	CcSEcCtD
Pimecrolimus—Rhinitis—Methylprednisolone—asthma	3.58e-05	0.000285	CcSEcCtD
Pimecrolimus—Pharyngitis—Triamcinolone—asthma	3.55e-05	0.000282	CcSEcCtD
Pimecrolimus—Eye disorder—Hydrocortisone—asthma	3.55e-05	0.000282	CcSEcCtD
Pimecrolimus—Hypersensitivity—Salbutamol—asthma	3.55e-05	0.000282	CcSEcCtD
Pimecrolimus—Pruritus—Montelukast—asthma	3.54e-05	0.000281	CcSEcCtD
Pimecrolimus—Conjunctivitis—Dexamethasone—asthma	3.52e-05	0.000279	CcSEcCtD
Pimecrolimus—Conjunctivitis—Betamethasone—asthma	3.52e-05	0.000279	CcSEcCtD
Pimecrolimus—Diarrhoea—Formoterol—asthma	3.49e-05	0.000278	CcSEcCtD
Pimecrolimus—Diarrhoea—Arformoterol—asthma	3.49e-05	0.000278	CcSEcCtD
Pimecrolimus—Nausea—Flunisolide—asthma	3.48e-05	0.000277	CcSEcCtD
Pimecrolimus—Vomiting—Mometasone—asthma	3.46e-05	0.000275	CcSEcCtD
Pimecrolimus—Hypersensitivity—Budesonide—asthma	3.44e-05	0.000273	CcSEcCtD
Pimecrolimus—Immune system disorder—Hydrocortisone—asthma	3.43e-05	0.000273	CcSEcCtD
Pimecrolimus—Rash—Mometasone—asthma	3.43e-05	0.000273	CcSEcCtD
Pimecrolimus—Dermatitis—Mometasone—asthma	3.43e-05	0.000272	CcSEcCtD
Pimecrolimus—Diarrhoea—Montelukast—asthma	3.42e-05	0.000272	CcSEcCtD
Pimecrolimus—Pruritus—Salbutamol—asthma	3.41e-05	0.000271	CcSEcCtD
Pimecrolimus—Headache—Mometasone—asthma	3.41e-05	0.000271	CcSEcCtD
Pimecrolimus—Erythema—Prednisolone—asthma	3.39e-05	0.000269	CcSEcCtD
Pimecrolimus—Eye disorder—Methylprednisolone—asthma	3.34e-05	0.000265	CcSEcCtD
Pimecrolimus—Malnutrition—Hydrocortisone—asthma	3.31e-05	0.000263	CcSEcCtD
Pimecrolimus—Erythema—Hydrocortisone—asthma	3.31e-05	0.000263	CcSEcCtD
Pimecrolimus—Pruritus—Budesonide—asthma	3.3e-05	0.000263	CcSEcCtD
Pimecrolimus—Diarrhoea—Salbutamol—asthma	3.3e-05	0.000262	CcSEcCtD
Pimecrolimus—Vomiting—Formoterol—asthma	3.25e-05	0.000258	CcSEcCtD
Pimecrolimus—Vomiting—Arformoterol—asthma	3.25e-05	0.000258	CcSEcCtD
Pimecrolimus—Nausea—Mometasone—asthma	3.23e-05	0.000257	CcSEcCtD
Pimecrolimus—Immune system disorder—Methylprednisolone—asthma	3.23e-05	0.000256	CcSEcCtD
Pimecrolimus—Rash—Formoterol—asthma	3.22e-05	0.000256	CcSEcCtD
Pimecrolimus—Rash—Arformoterol—asthma	3.22e-05	0.000256	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Methylprednisolone—asthma	3.22e-05	0.000256	CcSEcCtD
Pimecrolimus—Dermatitis—Arformoterol—asthma	3.22e-05	0.000256	CcSEcCtD
Pimecrolimus—Dermatitis—Formoterol—asthma	3.22e-05	0.000256	CcSEcCtD
Pimecrolimus—Headache—Arformoterol—asthma	3.2e-05	0.000254	CcSEcCtD
Pimecrolimus—Headache—Formoterol—asthma	3.2e-05	0.000254	CcSEcCtD
Pimecrolimus—Diarrhoea—Budesonide—asthma	3.2e-05	0.000254	CcSEcCtD
Pimecrolimus—Vomiting—Montelukast—asthma	3.18e-05	0.000253	CcSEcCtD
Pimecrolimus—Rash—Montelukast—asthma	3.15e-05	0.000251	CcSEcCtD
Pimecrolimus—Dermatitis—Montelukast—asthma	3.15e-05	0.00025	CcSEcCtD
Pimecrolimus—Headache—Montelukast—asthma	3.13e-05	0.000249	CcSEcCtD
Pimecrolimus—Erythema—Triamcinolone—asthma	3.12e-05	0.000248	CcSEcCtD
Pimecrolimus—Malnutrition—Methylprednisolone—asthma	3.11e-05	0.000247	CcSEcCtD
Pimecrolimus—Erythema—Methylprednisolone—asthma	3.11e-05	0.000247	CcSEcCtD
Pimecrolimus—Angioedema—Prednisolone—asthma	3.1e-05	0.000246	CcSEcCtD
Pimecrolimus—Vomiting—Salbutamol—asthma	3.07e-05	0.000244	CcSEcCtD
Pimecrolimus—Rash—Salbutamol—asthma	3.04e-05	0.000242	CcSEcCtD
Pimecrolimus—Dermatitis—Salbutamol—asthma	3.04e-05	0.000241	CcSEcCtD
Pimecrolimus—Eye disorder—Betamethasone—asthma	3.04e-05	0.000241	CcSEcCtD
Pimecrolimus—Eye disorder—Dexamethasone—asthma	3.04e-05	0.000241	CcSEcCtD
Pimecrolimus—Nausea—Arformoterol—asthma	3.03e-05	0.000241	CcSEcCtD
Pimecrolimus—Nausea—Formoterol—asthma	3.03e-05	0.000241	CcSEcCtD
Pimecrolimus—Angioedema—Hydrocortisone—asthma	3.02e-05	0.00024	CcSEcCtD
Pimecrolimus—Headache—Salbutamol—asthma	3.02e-05	0.00024	CcSEcCtD
Pimecrolimus—Back pain—Triamcinolone—asthma	3.01e-05	0.00024	CcSEcCtD
Pimecrolimus—Nausea—Montelukast—asthma	2.97e-05	0.000236	CcSEcCtD
Pimecrolimus—Vomiting—Budesonide—asthma	2.97e-05	0.000236	CcSEcCtD
Pimecrolimus—Rash—Budesonide—asthma	2.95e-05	0.000234	CcSEcCtD
Pimecrolimus—Dermatitis—Budesonide—asthma	2.94e-05	0.000234	CcSEcCtD
Pimecrolimus—Headache—Budesonide—asthma	2.93e-05	0.000233	CcSEcCtD
Pimecrolimus—Nausea—Salbutamol—asthma	2.86e-05	0.000228	CcSEcCtD
Pimecrolimus—Angioedema—Triamcinolone—asthma	2.85e-05	0.000226	CcSEcCtD
Pimecrolimus—Angioedema—Methylprednisolone—asthma	2.84e-05	0.000226	CcSEcCtD
Pimecrolimus—Erythema—Dexamethasone—asthma	2.83e-05	0.000225	CcSEcCtD
Pimecrolimus—Erythema—Betamethasone—asthma	2.83e-05	0.000225	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	2.8e-05	0.000222	CcSEcCtD
Pimecrolimus—Nausea—Budesonide—asthma	2.77e-05	0.00022	CcSEcCtD
Pimecrolimus—Oedema—Prednisolone—asthma	2.77e-05	0.00022	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisolone—asthma	2.77e-05	0.00022	CcSEcCtD
Pimecrolimus—Cough—Triamcinolone—asthma	2.72e-05	0.000216	CcSEcCtD
Pimecrolimus—Oedema—Hydrocortisone—asthma	2.7e-05	0.000215	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Hydrocortisone—asthma	2.7e-05	0.000215	CcSEcCtD
Pimecrolimus—Infection—Hydrocortisone—asthma	2.68e-05	0.000213	CcSEcCtD
Pimecrolimus—Nervous system disorder—Hydrocortisone—asthma	2.65e-05	0.00021	CcSEcCtD
Pimecrolimus—Arthralgia—Methylprednisolone—asthma	2.65e-05	0.00021	CcSEcCtD
Pimecrolimus—Eye disorder—Prednisone—asthma	2.64e-05	0.00021	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	2.63e-05	0.000209	CcSEcCtD
Pimecrolimus—Flushing—Prednisone—asthma	2.63e-05	0.000209	CcSEcCtD
Pimecrolimus—Skin disorder—Hydrocortisone—asthma	2.62e-05	0.000208	CcSEcCtD
Pimecrolimus—Angioedema—Betamethasone—asthma	2.58e-05	0.000205	CcSEcCtD
Pimecrolimus—Angioedema—Dexamethasone—asthma	2.58e-05	0.000205	CcSEcCtD
Pimecrolimus—Immune system disorder—Prednisone—asthma	2.56e-05	0.000203	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Triamcinolone—asthma	2.54e-05	0.000202	CcSEcCtD
Pimecrolimus—Oedema—Triamcinolone—asthma	2.54e-05	0.000202	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Methylprednisolone—asthma	2.54e-05	0.000202	CcSEcCtD
Pimecrolimus—Infection—Triamcinolone—asthma	2.53e-05	0.000201	CcSEcCtD
Pimecrolimus—Infection—Methylprednisolone—asthma	2.52e-05	0.0002	CcSEcCtD
Pimecrolimus—Nervous system disorder—Methylprednisolone—asthma	2.49e-05	0.000198	CcSEcCtD
Pimecrolimus—Paraesthesia—Prednisolone—asthma	2.48e-05	0.000197	CcSEcCtD
Pimecrolimus—Skin disorder—Methylprednisolone—asthma	2.47e-05	0.000196	CcSEcCtD
Pimecrolimus—Malnutrition—Prednisone—asthma	2.46e-05	0.000196	CcSEcCtD
Pimecrolimus—Erythema—Prednisone—asthma	2.46e-05	0.000196	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Hydrocortisone—asthma	2.46e-05	0.000196	CcSEcCtD
Pimecrolimus—Paraesthesia—Hydrocortisone—asthma	2.43e-05	0.000193	CcSEcCtD
Pimecrolimus—Pain—Prednisolone—asthma	2.37e-05	0.000188	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Hydrocortisone—asthma	2.33e-05	0.000185	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Triamcinolone—asthma	2.32e-05	0.000184	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Methylprednisolone—asthma	2.31e-05	0.000184	CcSEcCtD
Pimecrolimus—Pain—Hydrocortisone—asthma	2.31e-05	0.000184	CcSEcCtD
Pimecrolimus—Oedema—Dexamethasone—asthma	2.31e-05	0.000183	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Betamethasone—asthma	2.31e-05	0.000183	CcSEcCtD
Pimecrolimus—Oedema—Betamethasone—asthma	2.31e-05	0.000183	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Dexamethasone—asthma	2.31e-05	0.000183	CcSEcCtD
Pimecrolimus—Infection—Dexamethasone—asthma	2.29e-05	0.000182	CcSEcCtD
Pimecrolimus—Infection—Betamethasone—asthma	2.29e-05	0.000182	CcSEcCtD
Pimecrolimus—Paraesthesia—Triamcinolone—asthma	2.28e-05	0.000181	CcSEcCtD
Pimecrolimus—Paraesthesia—Methylprednisolone—asthma	2.28e-05	0.000181	CcSEcCtD
Pimecrolimus—Dyspnoea—Triamcinolone—asthma	2.27e-05	0.00018	CcSEcCtD
Pimecrolimus—Nervous system disorder—Betamethasone—asthma	2.26e-05	0.00018	CcSEcCtD
Pimecrolimus—Nervous system disorder—Dexamethasone—asthma	2.26e-05	0.00018	CcSEcCtD
Pimecrolimus—Angioedema—Prednisone—asthma	2.25e-05	0.000179	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Hydrocortisone—asthma	2.21e-05	0.000176	CcSEcCtD
Pimecrolimus—Urticaria—Prednisolone—asthma	2.2e-05	0.000175	CcSEcCtD
Pimecrolimus—Pain—Triamcinolone—asthma	2.18e-05	0.000173	CcSEcCtD
Pimecrolimus—Urticaria—Hydrocortisone—asthma	2.15e-05	0.000171	CcSEcCtD
Pimecrolimus—Body temperature increased—Hydrocortisone—asthma	2.14e-05	0.00017	CcSEcCtD
Pimecrolimus—Abdominal pain—Hydrocortisone—asthma	2.14e-05	0.00017	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Dexamethasone—asthma	2.1e-05	0.000167	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Betamethasone—asthma	2.1e-05	0.000167	CcSEcCtD
Pimecrolimus—Arthralgia—Prednisone—asthma	2.1e-05	0.000167	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	2.08e-05	0.000165	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Methylprednisolone—asthma	2.08e-05	0.000165	CcSEcCtD
Pimecrolimus—Paraesthesia—Betamethasone—asthma	2.07e-05	0.000165	CcSEcCtD
Pimecrolimus—Paraesthesia—Dexamethasone—asthma	2.07e-05	0.000165	CcSEcCtD
Pimecrolimus—Hypersensitivity—Prednisolone—asthma	2.04e-05	0.000162	CcSEcCtD
Pimecrolimus—Urticaria—Triamcinolone—asthma	2.02e-05	0.000161	CcSEcCtD
Pimecrolimus—Urticaria—Methylprednisolone—asthma	2.02e-05	0.00016	CcSEcCtD
Pimecrolimus—Body temperature increased—Triamcinolone—asthma	2.01e-05	0.00016	CcSEcCtD
Pimecrolimus—Oedema—Prednisone—asthma	2.01e-05	0.00016	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisone—asthma	2.01e-05	0.00016	CcSEcCtD
Pimecrolimus—Abdominal pain—Methylprednisolone—asthma	2.01e-05	0.000159	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—IL5—asthma	2e-05	0.000378	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PARP1—asthma	2e-05	0.000378	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TLR3—asthma	2e-05	0.000378	CbGpPWpGaD
Pimecrolimus—Infection—Prednisone—asthma	2e-05	0.000159	CcSEcCtD
Pimecrolimus—MTOR—Disease—DCN—asthma	2e-05	0.000377	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—asthma	1.99e-05	0.000376	CbGpPWpGaD
Pimecrolimus—Gastrointestinal disorder—Dexamethasone—asthma	1.99e-05	0.000158	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Betamethasone—asthma	1.99e-05	0.000158	CcSEcCtD
Pimecrolimus—Hypersensitivity—Hydrocortisone—asthma	1.99e-05	0.000158	CcSEcCtD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—IL6—asthma	1.98e-05	0.000375	CbGpPWpGaD
Pimecrolimus—Pain—Dexamethasone—asthma	1.97e-05	0.000157	CcSEcCtD
Pimecrolimus—Pain—Betamethasone—asthma	1.97e-05	0.000157	CcSEcCtD
Pimecrolimus—Nervous system disorder—Prednisone—asthma	1.97e-05	0.000157	CcSEcCtD
Pimecrolimus—MTOR—Signaling by ERBB4—IL6—asthma	1.95e-05	0.000369	CbGpPWpGaD
Pimecrolimus—Skin disorder—Prednisone—asthma	1.95e-05	0.000155	CcSEcCtD
Pimecrolimus—MTOR—Adaptive Immune System—PPP2CA—asthma	1.93e-05	0.000365	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—C3—asthma	1.93e-05	0.000365	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—BDKRB2—asthma	1.93e-05	0.000365	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PPP2CA—asthma	1.93e-05	0.000364	CbGpPWpGaD
Pimecrolimus—Pruritus—Hydrocortisone—asthma	1.91e-05	0.000152	CcSEcCtD
Pimecrolimus—FKBP1A—Disease—CCR5—asthma	1.89e-05	0.000357	CbGpPWpGaD
Pimecrolimus—Gastrointestinal pain—Betamethasone—asthma	1.89e-05	0.00015	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Dexamethasone—asthma	1.89e-05	0.00015	CcSEcCtD
Pimecrolimus—MTOR—Signaling by NGF—PTEN—asthma	1.89e-05	0.000356	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—PDGFB—asthma	1.88e-05	0.000355	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Triamcinolone—asthma	1.87e-05	0.000149	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—ADCY2—asthma	1.87e-05	0.000353	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Methylprednisolone—asthma	1.87e-05	0.000149	CcSEcCtD
Pimecrolimus—MTOR—Downstream signal transduction—IL6—asthma	1.87e-05	0.000352	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL3—asthma	1.86e-05	0.000352	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—C3—asthma	1.86e-05	0.000351	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—IL6—asthma	1.86e-05	0.000351	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Hydrocortisone—asthma	1.85e-05	0.000147	CcSEcCtD
Pimecrolimus—MTOR—Signaling by ERBB2—IL6—asthma	1.85e-05	0.000349	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PDE4A—asthma	1.84e-05	0.000348	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—KIF3A—asthma	1.84e-05	0.000348	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CRP—asthma	1.84e-05	0.000347	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—IL6—asthma	1.84e-05	0.000347	CbGpPWpGaD
Pimecrolimus—Urticaria—Dexamethasone—asthma	1.83e-05	0.000146	CcSEcCtD
Pimecrolimus—Urticaria—Betamethasone—asthma	1.83e-05	0.000146	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Prednisone—asthma	1.83e-05	0.000146	CcSEcCtD
Pimecrolimus—Abdominal pain—Dexamethasone—asthma	1.82e-05	0.000145	CcSEcCtD
Pimecrolimus—Body temperature increased—Dexamethasone—asthma	1.82e-05	0.000145	CcSEcCtD
Pimecrolimus—Abdominal pain—Betamethasone—asthma	1.82e-05	0.000145	CcSEcCtD
Pimecrolimus—Body temperature increased—Betamethasone—asthma	1.82e-05	0.000145	CcSEcCtD
Pimecrolimus—MTOR—Cellular responses to stress—VEGFA—asthma	1.82e-05	0.000343	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—PDGFB—asthma	1.81e-05	0.000341	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Prednisone—asthma	1.8e-05	0.000143	CcSEcCtD
Pimecrolimus—Pruritus—Triamcinolone—asthma	1.8e-05	0.000143	CcSEcCtD
Pimecrolimus—FKBP1A—Disease—PDGFB—asthma	1.8e-05	0.00034	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—STAT3—asthma	1.8e-05	0.00034	CbGpPWpGaD
Pimecrolimus—Pruritus—Methylprednisolone—asthma	1.8e-05	0.000143	CcSEcCtD
Pimecrolimus—MTOR—Immune System—CYBA—asthma	1.78e-05	0.000336	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1RN—asthma	1.78e-05	0.000336	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—TLR4—asthma	1.76e-05	0.000333	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—KNG1—asthma	1.76e-05	0.000332	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—AGTR1—asthma	1.75e-05	0.00033	CbGpPWpGaD
Pimecrolimus—Rash—Prednisolone—asthma	1.74e-05	0.000139	CcSEcCtD
Pimecrolimus—MTOR—Immune System—IL5—asthma	1.74e-05	0.000329	CbGpPWpGaD
Pimecrolimus—Dermatitis—Prednisolone—asthma	1.74e-05	0.000138	CcSEcCtD
Pimecrolimus—Diarrhoea—Methylprednisolone—asthma	1.74e-05	0.000138	CcSEcCtD
Pimecrolimus—Headache—Prednisolone—asthma	1.73e-05	0.000138	CcSEcCtD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—asthma	1.73e-05	0.000327	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—IL6—asthma	1.73e-05	0.000327	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—IL6—asthma	1.73e-05	0.000327	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DPB1—asthma	1.73e-05	0.000326	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CYSLTR1—asthma	1.73e-05	0.000326	CbGpPWpGaD
Pimecrolimus—Constipation—Prednisone—asthma	1.72e-05	0.000137	CcSEcCtD
Pimecrolimus—Vomiting—Hydrocortisone—asthma	1.72e-05	0.000136	CcSEcCtD
Pimecrolimus—MTOR—Signaling by EGFR—IL6—asthma	1.71e-05	0.000324	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL10—asthma	1.71e-05	0.000323	CbGpPWpGaD
Pimecrolimus—Rash—Hydrocortisone—asthma	1.7e-05	0.000135	CcSEcCtD
Pimecrolimus—Dermatitis—Hydrocortisone—asthma	1.7e-05	0.000135	CcSEcCtD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—IL6—asthma	1.7e-05	0.000321	CbGpPWpGaD
Pimecrolimus—Headache—Hydrocortisone—asthma	1.69e-05	0.000134	CcSEcCtD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-DRB1—asthma	1.69e-05	0.000319	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—IL6—asthma	1.69e-05	0.000319	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—STAT3—asthma	1.69e-05	0.000318	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NTRK1—asthma	1.68e-05	0.000316	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VIP—asthma	1.67e-05	0.000315	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CMA1—asthma	1.67e-05	0.000315	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—UTS2—asthma	1.67e-05	0.000315	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—C5AR1—asthma	1.67e-05	0.000315	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL11—asthma	1.67e-05	0.000315	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GSTP1—asthma	1.66e-05	0.000314	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TLR2—asthma	1.66e-05	0.000314	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD40—asthma	1.66e-05	0.000314	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ADRB2—asthma	1.66e-05	0.000313	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CYBA—asthma	1.64e-05	0.00031	CbGpPWpGaD
Pimecrolimus—Gastrointestinal pain—Prednisone—asthma	1.64e-05	0.000131	CcSEcCtD
Pimecrolimus—Nausea—Prednisolone—asthma	1.64e-05	0.000131	CcSEcCtD
Pimecrolimus—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.64e-05	0.00031	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTLA4—asthma	1.64e-05	0.000309	CbGpPWpGaD
Pimecrolimus—Pruritus—Dexamethasone—asthma	1.63e-05	0.00013	CcSEcCtD
Pimecrolimus—Pruritus—Betamethasone—asthma	1.63e-05	0.00013	CcSEcCtD
Pimecrolimus—MTOR—Immune System—ADCY2—asthma	1.63e-05	0.000307	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—ICAM1—asthma	1.62e-05	0.000307	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL3—asthma	1.62e-05	0.000306	CbGpPWpGaD
Pimecrolimus—Vomiting—Triamcinolone—asthma	1.62e-05	0.000129	CcSEcCtD
Pimecrolimus—Vomiting—Methylprednisolone—asthma	1.61e-05	0.000128	CcSEcCtD
Pimecrolimus—MTOR—Disease—PARP1—asthma	1.61e-05	0.000304	CbGpPWpGaD
Pimecrolimus—Nausea—Hydrocortisone—asthma	1.6e-05	0.000127	CcSEcCtD
Pimecrolimus—Rash—Triamcinolone—asthma	1.6e-05	0.000127	CcSEcCtD
Pimecrolimus—FKBP1A—Disease—NOS2—asthma	1.6e-05	0.000303	CbGpPWpGaD
Pimecrolimus—Dermatitis—Triamcinolone—asthma	1.6e-05	0.000127	CcSEcCtD
Pimecrolimus—Rash—Methylprednisolone—asthma	1.6e-05	0.000127	CcSEcCtD
Pimecrolimus—MTOR—Signaling Pathways—CCR4—asthma	1.6e-05	0.000302	CbGpPWpGaD
Pimecrolimus—Dermatitis—Methylprednisolone—asthma	1.6e-05	0.000127	CcSEcCtD
Pimecrolimus—Urticaria—Prednisone—asthma	1.6e-05	0.000127	CcSEcCtD
Pimecrolimus—Headache—Triamcinolone—asthma	1.59e-05	0.000127	CcSEcCtD
Pimecrolimus—Headache—Methylprednisolone—asthma	1.59e-05	0.000126	CcSEcCtD
Pimecrolimus—Body temperature increased—Prednisone—asthma	1.59e-05	0.000126	CcSEcCtD
Pimecrolimus—Abdominal pain—Prednisone—asthma	1.59e-05	0.000126	CcSEcCtD
Pimecrolimus—Diarrhoea—Betamethasone—asthma	1.58e-05	0.000125	CcSEcCtD
Pimecrolimus—Diarrhoea—Dexamethasone—asthma	1.58e-05	0.000125	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—ITPR1—asthma	1.57e-05	0.000296	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—STAT6—asthma	1.57e-05	0.000296	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD79A—asthma	1.56e-05	0.000295	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL2RB—asthma	1.54e-05	0.000291	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—EGFR—asthma	1.53e-05	0.000289	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—asthma	1.53e-05	0.000289	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GSTM1—asthma	1.53e-05	0.000289	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PDE4D—asthma	1.53e-05	0.000288	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS1—asthma	1.51e-05	0.000286	CbGpPWpGaD
Pimecrolimus—Nausea—Triamcinolone—asthma	1.51e-05	0.00012	CcSEcCtD
Pimecrolimus—MTOR—Innate Immune System—IL6R—asthma	1.51e-05	0.000285	CbGpPWpGaD
Pimecrolimus—Nausea—Methylprednisolone—asthma	1.51e-05	0.00012	CcSEcCtD
Pimecrolimus—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.51e-05	0.000285	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ADCY2—asthma	1.5e-05	0.000284	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD14—asthma	1.5e-05	0.000283	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CD86—asthma	1.49e-05	0.000282	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—C5—asthma	1.49e-05	0.000281	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PDE4B—asthma	1.49e-05	0.000281	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TACR1—asthma	1.49e-05	0.000281	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—EDN1—asthma	1.48e-05	0.00028	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Prednisone—asthma	1.48e-05	0.000118	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL5—asthma	1.47e-05	0.000278	CbGpPWpGaD
Pimecrolimus—Vomiting—Dexamethasone—asthma	1.47e-05	0.000117	CcSEcCtD
Pimecrolimus—Vomiting—Betamethasone—asthma	1.47e-05	0.000117	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—PLA2G4A—asthma	1.46e-05	0.000277	CbGpPWpGaD
Pimecrolimus—Rash—Betamethasone—asthma	1.46e-05	0.000116	CcSEcCtD
Pimecrolimus—Rash—Dexamethasone—asthma	1.46e-05	0.000116	CcSEcCtD
Pimecrolimus—Dermatitis—Dexamethasone—asthma	1.45e-05	0.000116	CcSEcCtD
Pimecrolimus—Dermatitis—Betamethasone—asthma	1.45e-05	0.000116	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—CSF2—asthma	1.45e-05	0.000274	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—VCAM1—asthma	1.45e-05	0.000273	CbGpPWpGaD
Pimecrolimus—Headache—Dexamethasone—asthma	1.45e-05	0.000115	CcSEcCtD
Pimecrolimus—Headache—Betamethasone—asthma	1.45e-05	0.000115	CcSEcCtD
Pimecrolimus—MTOR—Immune System—HLA-DQA1—asthma	1.44e-05	0.000272	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6R—asthma	1.44e-05	0.000272	CbGpPWpGaD
Pimecrolimus—Pruritus—Prednisone—asthma	1.42e-05	0.000113	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—SMAD3—asthma	1.41e-05	0.000266	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Prednisone—asthma	1.38e-05	0.000109	CcSEcCtD
Pimecrolimus—Nausea—Dexamethasone—asthma	1.37e-05	0.000109	CcSEcCtD
Pimecrolimus—Nausea—Betamethasone—asthma	1.37e-05	0.000109	CcSEcCtD
Pimecrolimus—MTOR—Immune System—ITPR1—asthma	1.36e-05	0.000258	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCR3—asthma	1.36e-05	0.000257	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—SERPINE1—asthma	1.35e-05	0.000255	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DQB1—asthma	1.35e-05	0.000255	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PPP2CA—asthma	1.35e-05	0.000255	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NPY—asthma	1.33e-05	0.00025	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCR5—asthma	1.32e-05	0.00025	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL2RA—asthma	1.31e-05	0.000247	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—RHOA—asthma	1.3e-05	0.000246	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD86—asthma	1.3e-05	0.000245	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—BCL2—asthma	1.3e-05	0.000245	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—C3—asthma	1.29e-05	0.000244	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS3—asthma	1.29e-05	0.000243	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL18—asthma	1.28e-05	0.000242	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AGTR2—asthma	1.28e-05	0.000241	CbGpPWpGaD
Pimecrolimus—Vomiting—Prednisone—asthma	1.28e-05	0.000102	CcSEcCtD
Pimecrolimus—MTOR—Immune System—CD40LG—asthma	1.27e-05	0.000241	CbGpPWpGaD
Pimecrolimus—Rash—Prednisone—asthma	1.27e-05	0.000101	CcSEcCtD
Pimecrolimus—Dermatitis—Prednisone—asthma	1.27e-05	0.000101	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—PDGFB—asthma	1.26e-05	0.000238	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD8A—asthma	1.26e-05	0.000238	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CSF2—asthma	1.26e-05	0.000238	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ITPR1—asthma	1.26e-05	0.000238	CbGpPWpGaD
Pimecrolimus—Headache—Prednisone—asthma	1.26e-05	0.0001	CcSEcCtD
Pimecrolimus—MTOR—Cellular responses to stress—IL6—asthma	1.26e-05	0.000237	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD4—asthma	1.24e-05	0.000235	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—AGER—asthma	1.23e-05	0.000232	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EDNRB—asthma	1.22e-05	0.000231	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TAC1—asthma	1.21e-05	0.000229	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NPS—asthma	1.21e-05	0.000229	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—LEP—asthma	1.21e-05	0.000228	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD86—asthma	1.2e-05	0.000227	CbGpPWpGaD
Pimecrolimus—Nausea—Prednisone—asthma	1.19e-05	9.49e-05	CcSEcCtD
Pimecrolimus—MTOR—Adaptive Immune System—CD4—asthma	1.19e-05	0.000225	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCR3—asthma	1.19e-05	0.000224	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CD4—asthma	1.19e-05	0.000224	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PTGS2—asthma	1.18e-05	0.000223	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—IL6—asthma	1.18e-05	0.000222	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PPP2CA—asthma	1.17e-05	0.000222	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CYBA—asthma	1.15e-05	0.000217	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—FN1—asthma	1.14e-05	0.000215	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL2RA—asthma	1.14e-05	0.000214	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SMAD3—asthma	1.13e-05	0.000214	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL5—asthma	1.13e-05	0.000213	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PARP1—asthma	1.13e-05	0.000213	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—C3—asthma	1.13e-05	0.000213	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PDGFB—asthma	1.1e-05	0.000207	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—BDKRB2—asthma	1.09e-05	0.000205	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PPP2CA—asthma	1.08e-05	0.000205	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—POMC—asthma	1.08e-05	0.000204	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—PTEN—asthma	1.08e-05	0.000203	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CRP—asthma	1.07e-05	0.000202	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CCR5—asthma	1.06e-05	0.000201	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ADCY2—asthma	1.05e-05	0.000199	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL3—asthma	1.05e-05	0.000198	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—POMC—asthma	1.04e-05	0.000196	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—PTEN—asthma	1.03e-05	0.000195	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PTEN—asthma	1.03e-05	0.000194	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TLR4—asthma	1.03e-05	0.000194	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DRB1—asthma	1.03e-05	0.000194	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LTC4S—asthma	1.02e-05	0.000192	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL2—asthma	1.01e-05	0.000191	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PDGFB—asthma	1.01e-05	0.000191	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6R—asthma	1.01e-05	0.000191	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—KNG1—asthma	9.89e-06	0.000187	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ICAM1—asthma	9.85e-06	0.000186	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AGTR1—asthma	9.83e-06	0.000186	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL10—asthma	9.61e-06	0.000181	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SERPINE1—asthma	9.46e-06	0.000179	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NTRK1—asthma	9.42e-06	0.000178	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ADRB2—asthma	9.33e-06	0.000176	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—STAT3—asthma	9.2e-06	0.000174	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RHOA—asthma	9.12e-06	0.000172	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NOS3—asthma	9.03e-06	0.00017	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS2—asthma	9.02e-06	0.00017	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LTA4H—asthma	8.83e-06	0.000167	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ITPR1—asthma	8.82e-06	0.000167	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6R—asthma	8.78e-06	0.000166	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—EGFR—asthma	8.74e-06	0.000165	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFB1—asthma	8.53e-06	0.000161	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CD86—asthma	8.4e-06	0.000159	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—EGFR—asthma	8.39e-06	0.000159	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—EGFR—asthma	8.36e-06	0.000158	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EDN1—asthma	8.33e-06	0.000157	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL5—asthma	8.27e-06	0.000156	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PLA2G4A—asthma	8.24e-06	0.000156	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CSF2—asthma	8.15e-06	0.000154	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6R—asthma	8.11e-06	0.000153	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL8—asthma	8.01e-06	0.000151	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SMAD3—asthma	7.93e-06	0.00015	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ARG1—asthma	7.72e-06	0.000146	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL2—asthma	7.65e-06	0.000145	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SERPINE1—asthma	7.59e-06	0.000143	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PPP2CA—asthma	7.59e-06	0.000143	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—BCL2—asthma	7.56e-06	0.000143	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IFNG—asthma	7.49e-06	0.000141	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCR5—asthma	7.45e-06	0.000141	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL2RA—asthma	7.34e-06	0.000139	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—RHOA—asthma	7.33e-06	0.000138	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—C3—asthma	7.28e-06	0.000137	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS3—asthma	7.25e-06	0.000137	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MMP9—asthma	7.24e-06	0.000137	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD4—asthma	7.24e-06	0.000137	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PTEN—asthma	7.2e-06	0.000136	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PDGFB—asthma	7.09e-06	0.000134	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALDH7A1—asthma	6.98e-06	0.000132	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LEP—asthma	6.78e-06	0.000128	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IL6—asthma	6.72e-06	0.000127	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ARG2—asthma	6.69e-06	0.000126	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1B—asthma	6.68e-06	0.000126	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD4—asthma	6.68e-06	0.000126	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL2—asthma	6.66e-06	0.000126	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PTGS2—asthma	6.63e-06	0.000125	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VEGFA—asthma	6.5e-06	0.000123	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—STAT3—asthma	6.44e-06	0.000122	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6—asthma	6.42e-06	0.000121	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—FN1—asthma	6.39e-06	0.000121	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PTEN—asthma	6.26e-06	0.000118	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TGFB1—asthma	5.97e-06	0.000113	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—EGFR—asthma	5.85e-06	0.000111	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—POMC—asthma	5.82e-06	0.00011	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PTEN—asthma	5.78e-06	0.000109	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL2—asthma	5.7e-06	0.000108	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6R—asthma	5.68e-06	0.000107	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—STAT3—asthma	5.6e-06	0.000106	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALOX5AP—asthma	5.55e-06	0.000105	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALOX15—asthma	5.55e-06	0.000105	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SERPINE1—asthma	5.32e-06	0.0001	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CHAT—asthma	5.29e-06	9.99e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—STAT3—asthma	5.17e-06	9.77e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RHOA—asthma	5.13e-06	9.69e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—EGFR—asthma	5.09e-06	9.62e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOS3—asthma	5.08e-06	9.59e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFB1—asthma	4.79e-06	9.05e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALOX5—asthma	4.72e-06	8.91e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—EGFR—asthma	4.7e-06	8.88e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL8—asthma	4.5e-06	8.51e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6—asthma	4.5e-06	8.5e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CARM1—asthma	4.5e-06	8.5e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—DCN—asthma	4.43e-06	8.37e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALDH2—asthma	4.31e-06	8.14e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL2—asthma	4.3e-06	8.13e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTT1—asthma	4.1e-06	7.75e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MMP9—asthma	4.07e-06	7.69e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PTEN—asthma	4.05e-06	7.65e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6—asthma	3.91e-06	7.39e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VEGFA—asthma	3.66e-06	6.91e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—STAT3—asthma	3.62e-06	6.84e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6—asthma	3.61e-06	6.82e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NQO1—asthma	3.41e-06	6.44e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFB1—asthma	3.36e-06	6.34e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ADCY2—asthma	3.34e-06	6.3e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—EGFR—asthma	3.29e-06	6.22e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTP1—asthma	2.84e-06	5.37e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HMOX1—asthma	2.8e-06	5.3e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ITPR1—asthma	2.8e-06	5.28e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CAT—asthma	2.77e-06	5.23e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PLA2G4A—asthma	2.61e-06	4.93e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GSTM1—asthma	2.61e-06	4.93e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6—asthma	2.53e-06	4.78e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PPP2CA—asthma	2.41e-06	4.54e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—POMC—asthma	1.85e-06	3.49e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALB—asthma	1.68e-06	3.18e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NOS3—asthma	1.61e-06	3.04e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGS2—asthma	1.47e-06	2.78e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTEN—asthma	1.28e-06	2.43e-05	CbGpPWpGaD
